Dermatol. praxi. 2010;4(1):42-45

Clinical outcomes of psoriasis treatment with infliximab - a case report

MUDr.Yvetta Vantuchová, Ph.D., MUDr.Veronika Pallová
Kožní oddělení FN Ostrava

A case of a 35-year-old woman is described who presented with many years of unstable psoriasis, periods of generalized manifestations

and significant joint pains in psoriatic arthropathy. For the past two years, this patient has been cared for by a rheumatologist who referred

her for worsening joint problems to the centre for biological therapy of psoriasis to assess the options of treatment with the tumour

necrosis factor-alpha (TNF-α) blocker. The clinical outcomes of treatment with infliximab (REMICADE) in psoriasis during the course of

26 months are presented. Psoriatic arthropathy is evaluated only in terms of affecting the intensity of joint pain.

Keywords: psoriasis, biological therapy, infliximab

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vantuchová Y, Pallová V. Clinical outcomes of psoriasis treatment with infliximab - a case report. Dermatol. praxi. 2010;4(1):42-45.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amital H, Ingber A, Rubinow A. Infliximab - induced remission of extensive plaque psoriasis. IMAJ, 2003; 5: 827-828. Go to PubMed...
    2. Benáková N, Štork J, et al. Léčba psoriázy biologiky. Čes.slov. Derm. 2006; 81(4): 1-11.
    3. Brimhall AK, King LN, Licciardone JC, et al. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a metaanalysis of randomized controlled trials. Br J Dermatol. 2008; 159(2): 274-285. Go to original source... Go to PubMed...
    4. Feldman SR, Gordon KB, Bala M, et al. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double - blind placebo - controlled trial. Br J Dermatol, 2005; 152: 954-960. Go to original source... Go to PubMed...
    5. Levy - Roy A, Porcher R, de Fonclare AL, et al. Efficacy of TNF-alpha antagonists for plaque-type psoriasis: A systematic review and graphical presentation. Ann Dermatol Venereol, 2009; 136(4): 315-322. Go to original source... Go to PubMed...
    6. Papp KA. Monitoring biologics for the treatment of psoriasis. Clin Dermatol. 2008; 26(5): 515-521. Go to original source... Go to PubMed...
    7. Reich K, Sinclair R, Roberts G, et al. Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaquetype psoriasis; a meta-analysis. Curr Med Res Opin. 2008; 24(5): 1237-1254. Go to original source... Go to PubMed...
    8. Schering-Plough: Souhrn údajů o přípravku (SPC) Remicade 2005.
    9. Svobodová E, Vantuchová Y. Naše zkušenosti s biologickou léčbo u psoriázy. Referátový výběr z dermatovenerologie. Speciál 2008; 50(1): 35-42.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.